Geode Capital Management’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.98M | Buy |
1,054,903
+122,137
| +13% | +$809K | ﹤0.01% | 2558 |
|
|
2025
Q1 | $8.54M | Sell |
932,766
-7,110
| -0.8% | -$65.1K | ﹤0.01% | 2389 |
|
|
2024
Q4 | $9.87M | Sell |
939,876
-620
| -0.1% | -$6.51K | ﹤0.01% | 2382 |
|
|
2024
Q3 | $11.2M | Buy |
940,496
+65,374
| +7% | +$781K | ﹤0.01% | 2309 |
|
|
2024
Q2 | $5.03M | Buy |
875,122
+450,358
| +106% | +$2.59M | ﹤0.01% | 2715 |
|
|
2024
Q1 | $2.21M | Buy |
424,764
+17,320
| +4% | +$90.1K | ﹤0.01% | 3077 |
|
|
2023
Q4 | $2.15M | Buy |
407,444
+22,742
| +6% | +$120K | ﹤0.01% | 3074 |
|
|
2023
Q3 | $1.27M | Buy |
384,702
+43,526
| +13% | +$144K | ﹤0.01% | 3230 |
|
|
2023
Q2 | $986K | Sell |
341,176
-295,927
| -46% | -$855K | ﹤0.01% | 3365 |
|
|
2023
Q1 | $682K | Buy |
637,103
+14,456
| +2% | +$15.5K | ﹤0.01% | 3527 |
|
|
2022
Q4 | $1.63M | Buy |
622,647
+30,249
| +5% | +$78.9K | ﹤0.01% | 3139 |
|
|
2022
Q3 | $4.15M | Buy |
592,398
+103,659
| +21% | +$725K | ﹤0.01% | 2766 |
|
|
2022
Q2 | $3.33M | Buy |
488,739
+39,359
| +9% | +$268K | ﹤0.01% | 2928 |
|
|
2022
Q1 | $6.34M | Buy |
449,380
+30,292
| +7% | +$427K | ﹤0.01% | 2653 |
|
|
2021
Q4 | $6.07M | Buy |
419,088
+197,760
| +89% | +$2.87M | ﹤0.01% | 2782 |
|
|
2021
Q3 | $3.13M | Buy |
221,328
+61,155
| +38% | +$866K | ﹤0.01% | 3167 |
|
|
2021
Q2 | $2.82M | Buy |
160,173
+25,172
| +19% | +$443K | ﹤0.01% | 3166 |
|
|
2021
Q1 | $2.06M | Buy |
+135,001
| New | +$2.06M | ﹤0.01% | 3240 |
|